(97 days)
The FDR D-EVO GL flat panel detector system is intended to capture for display radiographic images of human anatomy. It is intended for use in general projection radiographic applications including pediatic exams wherever conventional film/screen or CR systems may be used. This device is used to capture anatomic regions that are too large for conventional CR/DR format sizes. FDR D-EVO GL is not intended for mammography, fluoroscopy, tomography, and angiography applications.
Fujifilm's FDR D-EVO GL FPD System (DR-ID1300) is a digital detector system that interfaces with, and acquires and digitizes x-ray exposures from, standard radiographic systems. The DR-ID1300 is designed to be used in any environment that would typically use a radiographic cassette for examinations of adults and pediatrics including longlength exams where anatomic regions that are too large for conventional CR/DR format sizes, such as the entire spine or lower extremities, can be captured. The DR-ID1300 employs a new DR detector with a large exposure area size of ~ 17 x 49 inches. The detector can be placed in an appropriate stand for upright exams.
The provided text contains information about the FDR D-EVO GL Flat Panel Detector System (DR-ID1300) and its 510(k) submission. However, it explicitly states:
"Clinical Performance Data: No clinical study has been performed. The substantial equivalence has been demonstrated by non-clinical studies."
Therefore, I cannot provide details on acceptance criteria and a study proving the device meets those criteria from a clinical perspective because such a study was not performed. The substantial equivalence was demonstrated through non-clinical studies and comparisons to predicate devices.
The document mentions that the device conforms to voluntary standards (e.g., AAMI/ANSI ES60601-1, IEC 60601-1, IEC 60601-1-2, IEC 62304, IEC 62366, IEC 62494-1, and DICOM) and followed FDA guidance documents for solid-state X-ray imaging devices, software, and cybersecurity. These standards and guidances implicitly define performance requirements, but specific acceptance criteria and detailed performance metrics are not explicitly presented in a table format suitable for your request.
Based on the provided document, here's what can be inferred and what cannot be answered:
1. A table of acceptance criteria and the reported device performance:
- Cannot be provided as clinical performance data was not generated. The document only states that "All the major detector characteristics that may affect the image quality are substantially equivalent to the legally marketed DR-ID1201SE detector in K142003." and "The difference in MTF measurements is negligible, and the difference in DQE (Detective Quantum Efficiency) measurement is insignificant." These are comparative statements rather than specific acceptance criteria and reported performance values.
2. Sample size used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective):
- Not applicable / Not provided. No clinical test set was used for performance evaluation as no clinical study was performed. Non-clinical bench testing was "conducted to evaluate the long view attributes that are unique to the DR-ID1300 system," but details on sample size or data provenance for these non-clinical tests are not given.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience):
- Not applicable. No clinical ground truth was established as no clinical study was performed.
4. Adjudication method (e.g. 2+1, 3+1, none) for the test set:
- Not applicable. No clinical test set data was created that would require adjudication.
5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:
- No. The document explicitly states "No clinical study has been performed." Additionally, this device is a flat panel detector system, not an AI-based diagnostic tool, so an MRMC study comparing human readers with and without AI assistance would not be relevant.
6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done:
- Not applicable/Not provided. This is a hardware device (flat panel detector) that captures images, not an algorithm being evaluated for standalone performance. The "non-clinical studies" focused on validating its characteristics against a predicate device.
7. The type of ground truth used (expert consensus, pathology, outcomes data, etc):
- Not applicable. No clinical ground truth was established. The "ground truth" for the non-clinical studies would be instrument specifications, physics measurements, and comparisons to the predicate device's measured characteristics.
8. The sample size for the training set:
- Not applicable/Not provided. This device is a flat panel detector system, not a machine learning algorithm that requires a training set.
9. How the ground truth for the training set was established:
- Not applicable/Not provided. See above.
In summary, the provided document describes a 510(k) submission for a new flat panel detector system where substantial equivalence was demonstrated through non-clinical studies and comparisons to predicate devices, rather than through clinical performance data.
{0}------------------------------------------------
Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized caduceus symbol, which is a staff with two snakes entwined around it, overlaid on a circle. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged around the upper half of the circle.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
November 5, 2015
FUJIFILM Medical Systems U.S.A., Inc. % Ms. Katherine Choi Regulatory Affairs Manager 419 West Avenue STAMFORD CT 06902
Re: K152138
Trade/Device Name: FDR D-EVO GL Flat Panel Detector Svstem (DR-ID 1300) Regulation Number: 21 CFR 892.1680 Regulation Name: Stationary x-ray system Regulatory Class: II Product Code: MOB Dated: October 14, 2015 Received: October 15, 2015
Dear Ms. Choi:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21. Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
{1}------------------------------------------------
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638 2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours.
Michael D'Hara
For
Robert Ochs, Ph.D. Director Division of Radiological Health Office of In Vitro Diagnostics and Radiological Health Center for Devices and Radiological Health
Enclosure
{2}------------------------------------------------
Indications for Use
510(k) Number (if known) K152138
Device Name
FDR D-EVO GL Flat Panel Detector System (DR-ID 1300)
Indications for Use (Describe)
The FDR D-EVO GL flat panel detector system is intended to capture for display radiographic images of human anatomy. It is intended for use in general projection radiographic applications including pediatic exams wherever conventional film/screen or CR systems may be used. This device is used to capture anatomic regions that are too large for conventional CR/DR format sizes. FDR D-EVO GL is not intended for mammography, fluoroscopy, tomography, and angiography applications.
| Type of Use (Select one or both, as applicable) | |
|---|---|
| Prescription Use (Part 21 CFR 801 Subpart D) | Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
{3}------------------------------------------------
Image /page/3/Picture/0 description: The image shows the Fujifilm logo. The logo is black, except for a red square with a white triangle cut out of it. Below the logo is the text "Value from Innovation".
510(k) Summary
FDR D-EVO GL Flat Panel Detector System (DR-ID1300)
Date: October 30, 2015
Submitter's Information:
FUJIFILM Medical Systems U.S.A., Inc. 419 West Avenue Stamford, CT, 06902, USA
Contact Person:
| Name: | Katherine Y. Choi, RAC |
|---|---|
| Title: | Regulatory Affairs Manager |
| Telephone: | (203) 602-3568 |
| Facsimile: | (203) 602-3785 |
Identification of the Device:
| Proprietary/Trade Name: | FDR D-EVO GL Flat Panel Detector System(DR-ID1300) |
|---|---|
| Classification Name: | Stationary x-ray system |
| Regulations Number: | 21 CFR 892.1680 |
| Product Codes: | 90 MQB |
| Device Class: | Class II |
| Review Panel: | Radiology |
| Common Name: | Flat Panel Digital Detector System |
ldentification of the Legally Marketed Devices:
| Device Name | 510(k) # | Clearance Date |
|---|---|---|
| FDR D-EVO II Flat Panel Detector System (DR-ID1200) | K142003 | 10/21/2014 |
| FDR Image Stitching Option | K101686 | 10/29/2010 |
l. DEVICE DESCRIPTION
Fujifilm's FDR D-EVO GL FPD System (DR-ID1300) is a digital detector system that interfaces with, and acquires and digitizes x-ray exposures from, standard radiographic systems. The DR-ID1300 is designed to be used in any environment that would typically use a radiographic cassette for examinations of adults and pediatrics including longlength exams where anatomic regions that are too large for conventional CR/DR format sizes, such as the entire spine or lower extremities, can be captured. The DR-ID1300 employs a new DR detector with a large exposure area size of ~ 17 x 49 inches. The detector can be placed in an appropriate stand for upright exams.
{4}------------------------------------------------
Image /page/4/Picture/0 description: The image shows the Fujifilm logo. The logo is black, except for a small red square in the middle of the "I". Below the logo is the text "Value from Innovation".
Unlike DR stitching which typically requires multiple exposures, the DR-ID1300 needs a single exposure to capture the long view exams, therefore it requires less time in acquiring an image and is unlikely to be affected by patient movement. It not only eliminates the need of precise X-ray tube rotation control but also removes the need of exposing overlapping area when taking multiple exposures. Also requiring a single exposure streamlines the user's workflow.
The DR-ID1300 can be used with any leqally-marketed and appropriately certified X-ray source. However, use of the full detector area may require an increased source-toimage distance and increased technique factors which may exceed the capabilities of some x-ray systems. If the DR-ID1300 is used with the optional Hand Switch Interface Box, a connection to the X-ray source/generator's timing signals (prep and exposure signals) is necessary. Even if such timing signals are not available, the DR-ID1300 can acquire an image using Automatic x-ray detection function (known as 'SmartSwitch' in the US), so the limitation is negligible. In order to use the full effective area (~17x49") of the DR-ID1305SE detector, the X-ray source must be able to provide a large enough radiation field size to cover the entire effective area.
INDICATIONS FOR USE II.
The FDR D-EVO GL flat panel detector system is intended to capture for display radiographic images of human anatomy. It is intended for use in general projection radiographic applications including pediatric exams wherever conventional film/screen or CR systems may be used. This device is used to capture anatomic regions that are too large for conventional CR/DR format sizes. FDR D-EVO GL is not intended for mammography, fluoroscopy, tomography, and angiography applications.
SUMMARY OF TECHNOLOGICAL CHARACTERISTICS lll.
Fujifilm's FDR D-EVO GL FPD System (DR-ID1300) introduces the new DR-ID1305SE detector with a large ~17x49" exposure/active area, which allows a wider range of the general purpose radiography including long-view exams. All the major detector characteristics that may affect the image quality are substantially equivalent to the legally marketed DR-ID1201SE detector in K142003. For example, scintillator material (gadolinium oxysulfide (GOS)), indirect conversion method with Fujifilm's unique Irradiated Side Sampling (ISS) technology, pixel pitch (150µm), and resolution (16 bit) are the same. The difference in MTF measurements is negligible, and the difference in DQE (Detective Quantum Efficiency) measurement is insignificant. Because of DR-ID1305SE's large exposure/active area, appearance, weight, pixel matrix, external dimensions as well as preview time and cycle/exposure time are different from DR-ID1201SE. The new DR-ID1305SE detector supports wired data connection. Also FDR D-EVO GL FPD System (DR-ID1300)'s system configurations are very similar to the FDR D-EVO II in K142003, but a later version of FDX Console will support the DR-ID1300.
{5}------------------------------------------------
Image /page/5/Picture/0 description: The image shows the Fujifilm logo. The logo is black, except for a small red square with a white triangle cut out of it. Below the logo is the text "Value from Innovation".
SUBSTANTIAL EQUIVALENCE IV.
Fujifilm FDR D-EVO GL FPD System (DR-ID1300) is substantially equivalent to the following legally marketed devices.
| Legally Marketed Device | 510(k) # | Clearance Date |
|---|---|---|
| FDR D-EVO II Flat Panel Detector System (DR-ID1200) | K142003 | 10/21/2014 |
| FDR Image Stitching Option | K101686 | 10/29/2010 |
Both the new FDR D-EVO GL and legally marketed FDR D-EVO II are digital detector systems that are used to acquire x-ray exposures. Both systems are indicated for general purpose radiography including pediatric exams, but DR-ID1300 can be additionally used for long view exams where anatomic regions that are too large for conventional CR/DR format sizes, such as the entire spine or lower extremities, can be captured. This long-view exam indication is very similar to another legally marketed K101686 FDR Image Stitching Option.
Most detector characteristics remain unchanged, and the image quality is substantially equivalent to the legally marketed FDR D-EVO II.
V. SUMMARY OF STUDIES
Non-clinical Performance Data: FDR D-EVO GL FPD System (DR-ID1300) conforms to the voluntary standards such as AAMI/ANSI ES60601-1. IEC 60601-1. IEC 60601-1-2. IEC 62304, IEC 62366, IEC 62494-1 and DICOM. In addition, the FDA's Guidance for the Submission of 510(k)'s for Solid State X-ray Imaging Devices (issued on August 6, 1999) was followed to describe the detector characteristics. As required by the risk analysis necessary verification and validation activities were performed. For example, software changes were successfully evaluated according to the FDA's Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices (issued on May 11, 2005) based on a moderate level of concern. Cybersecurity recommendations of the FDA guidance, Content of Premarket Submissions for Management of Cybersecurity in Medical Devices (issued on October 2, 2014) were followed. Given that the new DR-ID1305SE detector's performance characteristics are equivalent to the currently marketed FDR D-EVO II detector in K142003, bench testing was conducted to evaluate the long view attributes that are unique to the DR-ID1300 system.
Clinical Performance Data: No clinical study has been performed. The substantial equivalence has been demonstrated by non-clinical studies.
VI. CONCLUSION
Based upon the supporting data summarized above, we concluded the FDR D-EVO GL Flat Panel Detector System (DR-ID1300) is as safe and effective as the legally marketed devices K142003 and K101686, and does not raise different questions of safety and effectiveness than the predicate devices.
§ 892.1680 Stationary x-ray system.
(a)
Identification. A stationary x-ray system is a permanently installed diagnostic system intended to generate and control x-rays for examination of various anatomical regions. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.(b)
Classification. Class II (special controls). A radiographic contrast tray or radiology diagnostic kit intended for use with a stationary x-ray system only is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 892.9.